SCHEMBL18952174

SCHEMBL18952174

NC1(c2ccccc2-c2ccc(Br)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 1/20 0.40
PTPRC P08575 1/20 0.36
SLC6A3 Q01959 1/20 0.36
NPC1 O15118 2/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
PLK4 O00444 1/20 0.35
AURKA O14965 1/20 0.35
JAK2 O60674 1/20 0.35
LCK P06239 1/20 0.35
CDK1 P06493 1/20 0.35
CSF1R P07333 1/20 0.35
LYN P07948 1/20 0.35
FGFR1 P11362 1/20 0.35
SRC P12931 1/20 0.35
PRKACA P17612 1/20 0.35
RPS6KB1 P23443 1/20 0.35
CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31360017 0.84 ALDH1A1 (0.43) ALDH1A1MAPK1SLC6A3HPGD
SCHEMBL25155914 0.84 ALDH1A1 (0.43) ALDH1A1MAPK1SLC6A3HPGD
SCHEMBL18952107 0.81 PTGS2 (0.43) SLC6A3NPC1MEN1KMT2AFGFR1
SCHEMBL20491056 0.81 PTGS2 (0.43) SLC6A3AKT1AKT2PDK2
SCHEMBL25155269 0.78 NOTUM (0.40) ALDH1A1MAPK1NPC1AURKACDK1
SCHEMBL31360144 0.78 NOTUM (0.40) ALDH1A1MAPK1NPC1AURKACDK1
SCHEMBL24582841 0.77 MAPT (0.40) SLC6A3NPC1MEN1KMT2AMAPT
SCHEMBL646392 0.73 HTR2A (0.43)
SCHEMBL29669136 0.73 HTR2A (0.43)
SCHEMBL19125933 0.72 ALDH1A1 (0.63) ALDH1A1MAPK1PTPRCSLC6A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017097865-A9 COMBINATION OF CALORIC RESTRICTION (CR) OR IGF1/INSULIN RECEPTOR INHIBITOR WITH LSD1 INHIBITOR ISTITUTO EUROPEO DI ONCOLOGIA (IT) 2017-08-31 WO disclosed
WO-2017097865-A1 COMBINATION OF CALORIC RESTRICTION (CR) OR IGF1/INSULIN RECEPTOR INHIBITOR WITH LSD1 INHIBITOR ISTITUTO EUROPEO DI ONCOLOGIA (IT) 2017-06-15 WO disclosed